Volunteer Donate Get Help

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

Renegade Cells Portend Relapse

Published: March 05, 2018

Source: Stanford Medicine

Researchers at the Stanford University School of Medicine have developed a technique that allowed them to determine at diagnosis whether children with acute lymphoblastic leukemia would relapse following tre ... More >>.

Things to Know About CAR T-cell Therapy

Published: February 28, 2018

Author: Cynthia DeMarco

Source: MD Anderson Cancer Center

CAR T-cell therapy is a new type of cancer treatment offered at MD Anderson through clinical trials and FDA-approved standard of care cell therapy products. But what exactly is CAR T-cell therapy? Based on i ... More >>.

Choosing a TKI for CML

Published: February 01, 2018

Author: Bryant Furlow

Source: Cancer Therapy Advisor

The BCR-ABL tyrosine kinase inhibitors (TKIs) were an early example of a successful targeted cancer treatment and have dramatically improved outcomes for patients diagnosed with chronic myeloid leukemia (CML ... More >>.

Vaccine Eliminates Cancer Tumors

Published: January 31, 2018

Author: Steve Fisch

Source: Stanford University Medical Center

Ronald Levy and Idit Sagiv-Barfi led the work on a possible cancer treatment that involves injecting two immune-stimulating agents directly into solid tumors. Injecting minute amounts of two immune-stimulati ... More >>.

Stopping Treatment for CML

Published: January 30, 2018

Author: Andrea Greif

Source: Leukemia & Lymphoma Society

When the targeted oral therapy, imatinib (Gleevec) was approved by the U.S. Food & Drug Administration (FDA) in 2001, it revolutionized treatment for patients with chronic myeloid leukemia (CML), turning ... More >>.

Melting Away of Leukemia

Published: January 08, 2018

Source: Cold Spring Harbor Laboratory

Cancer researchers today announced they have developed a way of sideling one of the most dangerous "bad actors" in leukemia. Their approach depends on throwing a molecular wrench into the gears of an importa ... More >>.

Gene Variants Identified

Published: January 04, 2018

Source: St. Jude Children's Research Hospital

Newly identified germline variations in a key tumor suppressor gene predispose individuals to develop leukemia as children and leave them with a 1-in-4 chance of developing a second cancer later. St. Jude Ch ... More >>.

Loophole in CLL Treatment

Published: January 04, 2018

Source: Rockefeller University Press

A team of researchers in Italy and Austria has determined that a drug approved to treat chronic lymphocytic leukemia (CLL) may be less effective in a particular subset of patients. The study, which will be p ... More >>.

AML Study Reports High Reponse Rates

Published: December 11, 2017

Source: M.D. Anderson Cancer Center

Initial findings from a multi-national open label phase study of inhibitory drug therapy for relapsed or refractory acute myeloid leukemia (AML) have demonstrated a complete response in up to 50 percent pati ... More >>.

CAR T Therapy for non-Hodgkin's Lymphoma

Published: December 10, 2017

Source: University of Pennsylvania School of Medicine

In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah demonstrated long-lasting remissions in non-Hodgkin's lymphoma (NHL) patients. R ... More >>.

©2015 Stephanie Robinson Foundation | Privacy Policy